Integrated psychological therapy: effectiveness in schizophrenia inpatient settings related to patients' age.

Integrated psychological therapy: effectiveness in schizophrenia inpatient settings related to patients' age. Am J Geriatr Psychiatry. 2013 Mar;21(3):231-41 Authors: Mueller DR, Schmidt SJ, Roder V Abstract OBJECTIVE: Elderly people with schizophrenia often suffer from cognitive impairments, which affect their social functioning. Today, only a few therapy approaches for middle-aged and older patients are available. The Integrated Psychological Therapy (IPT) combines neurocognitive and social cognitive interventions with social skills approaches. The aim of this study was to evaluate (1) whether IPT is effective in younger patients (age 
Source: Am J Geriatr Psychia... - Category: Geriatrics Authors: Tags: Am J Geriatr Psychiatry Source Type: research

Related Links:

Authors: Hatila S, Solanki G PMID: 32470234 [PubMed - as supplied by publisher]
Source: The Primary Care Companion for CNS Disorders - Category: Primary Care Tags: Prim Care Companion CNS Disord Source Type: research
CONCLUSIONS: People with schizophrenia do not have a higher overall incidence of cancer than people in the general population. However, there are significant differences in the risk of specific cancer types overall and by sex calling for efforts to develop disease-specific prevention programmes. In people with schizophrenia, higher risk generally occurs in those
Source: Epidemiology and Psychiatric Sciences - Category: Psychiatry Tags: Epidemiol Psychiatr Sci Source Type: research
The goal of this proposed initiative is to advance translational research to better understand the emergence and worsening of mood and psychotic disorders (e.g., PMD, generalized anxiety disorder, bipolar disorder, and schizophrenia) during the MT to identify targets for future development of novel treatment interventions.
Source: National Institute of Mental Health - Category: Psychiatry Authors: Source Type: news
Conclusion: The present study demonstrated new information regarding the prescription patterns of psychotropic drugs in outpatients with PSD in Serbia, amplified with clinically relevant information. This study also revealed distinct prescription patterns concerning antipsychotic/benzodiazepine polypharmacy. Overall, such findings are likely to contribute to improving clinical practice and care for patients with PSD in general.KeypointsPresent exploratory research aimed to elucidate trends of antipsychotics polypharmacy and concomitant use of psychotropic medications including benzodiazepines in the maintenance treatment o...
Source: International Journal of Psychiatry in Clinical Practice - Category: Psychiatry Tags: Int J Psychiatry Clin Pract Source Type: research
Clozapine is thought to induce obsessive compulsive symptoms (OCS) in schizophrenic patients. However, because OCS are often comorbid with schizophrenia regardless of clozapine treatment, it remains unclear wh...
Source: Molecular Brain - Category: Neuroscience Authors: Tags: Micro report Source Type: research
DiscussionThese findings behoove clinicians to be mindful when evaluating patients' need to be on LAI antipsychotics amidst multifaceted considerations, especially downstream adverse events such as metabolic and extrapyramidal side effects.
Source: Asia-Pacific Psychiatry - Category: Psychiatry Authors: Tags: ORIGINAL ARTICLE Source Type: research
In this study we aimed to assess the levels of adiponectin, insulin, leptin, glucose, total cholesterol, lipoproteins and triglycerides in FEP patients, unaffected offspring of schizophrenia patients (FHR-P individuals) and healthy controls (HCs) with respect to cognitive performance and psychopathological manifestation. Participants were 35 FEP patients, 33 FHR-P individuals, and 32 HCs. Cognitive performance was assessed using the Repeatable Battery for Assessment of Neuropsychological Status (RBANS). The levels of leptin and high-density lipoproteins (HDL) were significantly lower (leptin: 10.7 ± 15.7 vs. 12.6 &p...
Source: Frontiers in Psychiatry - Category: Psychiatry Source Type: research
Publication date: Available online 28 May 2020Source: Progress in Neuro-Psychopharmacology and Biological PsychiatryAuthor(s): Matsuhiko Oka, Koki Ito, Minori Koga, Ichiro Kusumi
Source: Progress in Neuro Psychopharmacology and Biological Psychiatry - Category: Psychiatry Source Type: research
CONCLUSION: Olanzapine was considered the most cost-effective drug for the first-line treatment of schizophrenia in Brazil. Aripiprazole was dominated by risperidone and was not considered cost-effective against olanzapine. IMPLICATIONS FOR HEALTH CARE PROVISION AND USE: This work demonstrated, using a price adjustment process, that there is no viable price that would make aripiprazole cost-effective for incorporation in the Brazilian public health system in the first-line of treatment of schizophrenia. The drug can be useful in specific cases, since individual variability of response to antipsychotic drugs is importan...
Source: Journal of Mental Health Policy and Economics - Category: Psychiatry Tags: J Ment Health Policy Econ Source Type: research
Publication date: Available online 28 May 2020Source: Neuroscience LettersAuthor(s): Frederico Rogério Ferreira, Nathalia Souza Barros de Moura, Lucas Hassib Camina, Thatiane Rebelo Pombo
Source: Neuroscience Letters - Category: Neuroscience Source Type: research
More News: Geriatrics | Neurology | Psychiatry | Psychology | Schizophrenia | Study